Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine

Clinical and Investigative Medicine

Volumn 22, Issue 4, 1999, Pages 132-139

  Ward, Leanne ^a   Huot, Céline ^a   Lambert, Raymond ^a   Deal, Cheri ^a   Collu, Robert ^a   Van Vliet, Guy ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; IODINE 131; LEVOTHYROXINE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE;

ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; MALE; NAUSEA; PEDIATRICS; PRIORITY JOURNAL; PRURITUS; RETROSPECTIVE STUDY; THYROID FUNCTION; TREATMENT OUTCOME; VOMITING;

EID: 0032752647     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. DiGeorge AM, LaFranchi S. Hyperthyroidism. In: Behrman RE, Kliegman RM, Arvin AM, editors. Nelson Textbook of Paediatrics. 14th Ed. Philadelphia: WB Saunders; 1996. p. 1600-2.
2. Perrild H, Grüters-Kieslich A, Feldt-Rasmussen U, Grant D, Martino E, Kayser L, et al. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. Eur J Endocrinol 1994;131:467-73.
3. LaFranchi S, Mandel SH. Graves' disease in the neonatal period and childhood. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's the Thyroid. 7th Ed. Philadelphia: Lippincott-Raven; 1996. p. 1000-8.
4. Hamburger JI. Management of hyperthyroidism in children and adolescents. J Clin Endocrinol Metab 1985;60:1019-24.
5. Hayek A, Chapman EM, Crawford JD. Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine. N Engl J Med 1970;283:949-53.
6. Crile G Jr, Schumacker OP. Radioactive iodine treatment of Graves' disease. Am J Dis Child 1965;110:501-4.
7. Freitas JE, Swanson DP, Gross MD, Sisson JC. Iodine-131: Optimal therapy for hyperthyroidism in children and adolescents? J Nucl Med 1979;20:847-50.
8. Starr P, Jaffe HL, Oettinger L Jr. Late results of 131I treatment of hyperthyroidism in seventy-three children and adolescents. J Nucl Med 1964;5:81-9.
9. Halnan KE. Risks from radioiodine treatment of thyrotoxicosis. BMJ 1983;287:1821-2.
10. Hennemann G, Krenning EP, Sankaranarayanan K. Place of radioactive iodine in treatment of thyrotoxicosis. Lancet 1986;1:1369-71.
11. Cheetham TD, Hughes IA, Barnes ND, Wraight EP. Treatment of hyperthyroidism in young people. Arch Dis Child 1998;78:207-9.
12. Cheetham RD, Wraight P, Hughes IA, Barnes ND. Radiodioine treatment of Graves' disease in young people. Horm Res 1998;49:258-62.
13. Dunn JT. Choice of therapy in young adults with hyperthyroidism of Graves' disease. Ann Intern Med 1984;100:891-3.
14. Barnes HV, Blizzard RM. Antithyroid drug therapy for toxic diffuse goiter (Graves disease): Thirty years experience la children and adolescents. J Pediatr 1977;91:313-20.
15. Kogut MD, Kaplan SA, Collipp PJ, Tiamsic T, Boyle D. Treatment of hyperthyroidism in children. Analysis of forty-five patients. N Engl J Med 1965;272:217-21.
16. Safa AM, Schumacher OP, Rodriguez-Antunez A. Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. N Engl J Med 1975;292:167-71.
17. Ching T, Warden MJ, Fefferman RA. Thyroid surgery in children and teenagers. Arch Otolaryngol 1977;103:544-6.
18. Grüters, A. Treatment of Graves' disease in children and adolescents. Horm Res 1998;49:255-7.
19. Gorton C, Sadeghi-Nejad A, Senior B. Remission in children with hyperthyroidism treated with propylthioracil. Long-term results. Am J Dis Child 1987;141:1084-6.
20. Franklyn JA. The management of hyperthyroidism. N Engl J Med 1994;330:1731-8.
21. Cooper, DS. Treatment of thyrotoxicosis. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's the Thyroid. 7th Ed. Philadelphia: Lippincott-Raven; 1996. p. 713-34.
22. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with long term medical therapy: Twenty-five percent remission every two years. J Clin Endocrinol Metab 1987;64:1241-5.
23. Karlsson, FA. Childhood Graves' disease - Remission rate and risk factors. J Clin Endocrinol Metab 1998;83:1398.
24. Shulman DL, Muhar I, Jorgensen EV, Diamond FB, Bercu BB, Root AW. Autoimmune hyperthyroidism in prepubertal children and adolescents: Comparison of clinical and biochemical features at diagnosis and responses to medical therapy. Thyroid 1997;7:755-60.
25. Siok-Hoon T, Bee-Wah L, Hock-Boon W, Uma R. Relapse markers in childhood thyrotoxicosis. Clin Pediatr 1987;26:136-9.
26. Glaser NS, Styne DM. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 1997;82:1719-26.
27. Allannic H, Fauchet R, Lorcy Y, Gueguen M, Le Guerrier A-M, Genetet B. A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype. J Clin Endocrinol Metab 1983;57:719-22.
28. Sarkar SD, Beierwaltes WH, Satinder PG, Cowley BJ. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer. J Nucl Med 1976;17:460-4.
29. Rivkees SA, Sklar C, Freemark M. The management of Graves' disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 1998;83:3767-76.
30. Dobyns BM, Sheline GE, Workman JB, Tompkins EA, McConahey WM, Becker DV. Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: A report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol Metab 1974;38:976-98.
31. Holm L-E, Hall P, Wiklund K, et al. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 1991;83:1072-7.
32. Malvaux P. Thyroid fuction during the neonatal period, infancy and childhood. In: Delange F, Fisher DA, Malvaux P. Pediatric thyroidology. Basel: Karger; 1985. p. 33-43.
33. Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease. Clin Endocrinol 1997;47:425-30.
34. Kung AW, Yau CC, Cheng AC. The action of methimazole and I-thyroxine in radioiodine therapy: A prospective study on the incidence of hypothyroidism. Thyroid 1995;5(1):7-12.
35. Clark JD, Gelfand MJ, Elgazzar AH. Iodine-13I therapy of hyperthyroidism in pediatric patients. J Nucl Med 1995;36:442-5.
36. Alvin P, Rey C, Frappier, JY. Compliance thérapeutique chez l'adolescent malade chronique. Arch Pédiatr 1995;2:874-82.
37. Cramer JA. Overview of methods to measure and enhance patient compliance. In: Cramer JA, Spilker B, editors. Patient Compliance in Medical Practice and Clinical Trials. New York: Raven; 1991. p. 3-10.
38. MacFarlane IA, Davies D, Longson D, Shalet SM, Beardwell CG. Single daily dose short term carbimazole therapy for hyperthyroid Graves' disease. Clin Endocrinol 1983;18:557-61.
39. Shiroozu A, Okamura K, Ikenoue H, et al. Treatment of hyperthyroidism with a small daily dose of methimazole. J Clin Endocrinol Metab 1986;63:125-8.
40. Gambert SR. Intrinsic and extrinsic variables. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's the Thyroid. 7th Ed. Philadelphia: Lippincott-Raven; 1996. p. 254-327.
41. Saggese G, Bertelloni S, Baroncelli GI. Bone mineralization and calciotropic hormones in children with hyperthyroidism. Effects of methimazole therapy. J Endocrinol Invest 1990;13:587-92.